Literature DB >> 15743834

p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.

Asmaà Fritah1, Cécile Saucier, Jan Mester, Gérard Redeuilh, Michèle Sabbah.   

Abstract

Estrogen receptors (ER) are ligand-dependent transcription factors that regulate growth, differentiation, and maintenance of cellular functions in a wide variety of tissues. We report here that p21WAF1/CIP1, a cyclin-dependent kinase (Cdk) inhibitor, cooperates with CBP to regulate the ERalpha-mediated transcription of endogenous target genes in a promoter-specific manner. The estrogen-induced expression of the progesterone receptor and WISP-2 mRNA transcripts in MCF-7 cells was enhanced by p21WAF1/CIP1, whereas that of the cyclin D1 mRNA was reduced and the pS2 mRNA was not affected. Chromatin immunoprecipitation assays revealed that p21WAF1/CIP1 was recruited simultaneously with ERalpha and CBP to the endogenous progesterone receptor gene promoter in an estrogen-dependent manner. Experiments in which the p21WAF1/CIP1 protein was knocked down by RNA interference showed that the induction of the expression of the gene encoding the progesterone receptor required p21WAF1/CIP1, in contrast with that of the cyclin D1 and pS2 genes. p21WAF1/CIP1 induced not only cell cycle arrest in breast cancer cells but also milk fat globule protein and lipid droplets, indicators of the differentiated phenotype, as well as cell flattening and increase of the volume of the cytoplasm. These results indicate that p21WAF1/CIP1, in addition to its Cdk-regulatory role, behaves as a transcriptional coactivator in a gene-specific manner implicated in cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743834      PMCID: PMC1061593          DOI: 10.1128/MCB.25.6.2419-2430.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  75 in total

Review 1.  Cdk inhibitors in development and cancer.

Authors:  J W Harper; S J Elledge
Journal:  Curr Opin Genet Dev       Date:  1996-02       Impact factor: 5.578

Review 2.  Estrogens and breast cancer.

Authors:  H S Feigelson; B E Henderson
Journal:  Carcinogenesis       Date:  1996-11       Impact factor: 4.944

3.  p300 is a component of an estrogen receptor coactivator complex.

Authors:  B Hanstein; R Eckner; J DiRenzo; S Halachmi; H Liu; B Searcy; R Kurokawa; M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Role of CBP/P300 in nuclear receptor signalling.

Authors:  D Chakravarti; V J LaMorte; M C Nelson; T Nakajima; I G Schulman; H Juguilon; M Montminy; R M Evans
Journal:  Nature       Date:  1996-09-05       Impact factor: 49.962

5.  p21(Waf1/Cip1) and p53 protein expression in breast cancer.

Authors:  E Wakasugi; T Kobayashi; Y Tamaki; Y Ito; I Miyashiro; Y Komoike; T Takeda; E Shin; Y Takatsuka; N Kikkawa; T Monden; M Monden
Journal:  Am J Clin Pathol       Date:  1997-06       Impact factor: 2.493

6.  Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines.

Authors:  D Coradini; A Biffi; C Pellizzaro; E Pirronello; G Di Fronzo
Journal:  Tumour Biol       Date:  1997

7.  Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

Authors:  O W Prall; B Sarcevic; E A Musgrove; C K Watts; R L Sutherland
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

8.  Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.

Authors:  N D Perkins; L K Felzien; J C Betts; K Leung; D H Beach; G J Nabel
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

9.  The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.

Authors:  M B Datto; P P Hu; T F Kowalik; J Yingling; X F Wang
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

10.  Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit.

Authors:  R M Zwijsen; R Klompmaker; E B Wientjens; P M Kristel; B van der Burg; R J Michalides
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more
  33 in total

1.  p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth.

Authors:  Peter F Vitiello; Rhonda J Staversky; Sean C Gehen; Carl J Johnston; Jacob N Finkelstein; Terry W Wright; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  Negative control of CSL gene transcription by stress/DNA damage response and p53.

Authors:  Elena Menietti; Xiaoying Xu; Paola Ostano; Jean-Marc Joseph; Karine Lefort; G Paolo Dotto
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

3.  E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.

Authors:  Luis A Carvajal; Pierre-Jacques Hamard; Crystal Tonnessen; James J Manfredi
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

4.  Transcriptome analysis of monocyte-HIV interactions.

Authors:  Rafael Van den Bergh; Eric Florence; Erika Vlieghe; Tom Boonefaes; Johan Grooten; Erica Houthuys; Huyen Thi Thanh Tran; Youssef Gali; Patrick De Baetselier; Guido Vanham; Geert Raes
Journal:  Retrovirology       Date:  2010-06-14       Impact factor: 4.602

5.  CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.

Authors:  Michèle Sabbah; Céline Prunier; Nathalie Ferrand; Virginie Megalophonos; Kathleen Lambein; Olivier De Wever; Nicolas Nazaret; Joël Lachuer; Sylvie Dumont; Gérard Redeuilh
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

6.  Multiple functions of Kip-related protein5 connect endoreduplication and cell elongation.

Authors:  Teddy Jégu; David Latrasse; Marianne Delarue; Christelle Mazubert; Mickaël Bourge; Elodie Hudik; Sophie Blanchet; Marie-Noëlle Soler; Céline Charon; Lieven De Veylder; Cécile Raynaud; Catherine Bergounioux; Moussa Benhamed
Journal:  Plant Physiol       Date:  2013-02-20       Impact factor: 8.340

Review 7.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

8.  The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Authors:  Luke F Peterson; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

9.  Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.

Authors:  Asmaà Fritah; Cécile Saucier; Olivier De Wever; Marc Bracke; Ivan Bièche; Rosette Lidereau; Christian Gespach; Sylvain Drouot; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

10.  The orphan nuclear receptor SHP inhibits apoptosis during the monocytic differentiation by inducing p21WAF1.

Authors:  Kyeongjin Kim; Yoon Ha Choi; Hyeong Hoe Kim; Jaehun Cheong
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.